Variables | Assigned score | Hazard ratio | 95Â % CI | P-value |
---|---|---|---|---|
Age | ||||
 ≤64 | 0 | 1.51 | 0.82–2.94 | 0.169 |
 >64 | 1 |  |  |  |
Sex | ||||
 Female | 0 | 1.18 | 0.60–2,33 | 0.623 |
 Male | 1 |  |  |  |
Differentiation | ||||
 Well | 0 | 1.09 | 0.53–2.94 | 0.803 |
 Moderate & poor | 1 |  |  |  |
T-stage | ||||
 T1 & T2 | 0 | 0.871 | 0.39–1.90 | 0.728 |
 T3 & T4 | 1 |  |  |  |
Clinical stage | ||||
 Early (1 & 2) | 0 | 1.371 | 0.55–3.33 | 0.494 |
 Late (3 & 4) | 1 |  |  |  |
S100A16 | ||||
 High | 0 | 0.483 | 0.24–0.95 | 0.037 |
 Low | 1 |  |  |  |